Aulon Group SL
OMNIA MATER
Development of environmental-friendly biomaterials and biomaterials-based products
Coordinates the four companies
BIOACTIVE SURFACES
Funcionalization of inorganic materials with peptides and proteins, advanced 3D tissue bioprinting
biofuncionalized prostheses 3D tissue bioprinting biofuncionalized AFM tips
SILK BIOMED
Silk fibroin-based biomedical products for the regeneration and repair of human organs and tissues
Tissue engineering cellular and molecular therapies
HUMAN RETINA
Personalized therapies for eye diseases and retina neurodegenerative disorders
Retinas-on-Chip artificial retinas ELVs for AMD treatment
Pioneer Advanced Biotechnology, biomaterials and functionalization technologies, cellular and molecular therapies, tissue engineering and regenerative medicine
We are:
- Fast
- Highly competent and efficient
- Capable of delivering cutting-edge solutions under tight timelines
Our products:
- Molecular therapies for ischemic stroke and age-related macular degeneration (both of them entering clinical trials)
- Retina-on-chip platforms for drug screening
- Adaptive drug delivery systems
- Biofunctionalized prostheses
- Spider-like 3D tissue bioprinters
- Precision AFM tips
The Pillars of Aulon Innovation

STRATEGIC MULTI-COMPANY INTEGRATION
Aulon comprises Omnia Mater, Bioactive Surfaces, Human Retina and Slik Biomed

ADVANCED THERAPEUTIC SPECIALTIES
Focus on cellular therapies, tissue engineering, and biohybrid regenerative biomaterials

GLOBAL RESEARCH LEADERSHIP
Currently coordinating prestigious EU Pathfinder projects including ISOS and THOB
Global Research Leadership
ISOS
THOR

BRBoC
